RecruitingNCT05624905

Prospective Pecutaneous Coronary Intervention Registry

Prospective Registry for Identifying Long-term Prognosis in Patients Who Underwent Coronary Angiography and Percutaneous Coronary Intervention for Coronary Artery Disease


Sponsor

Samsung Medical Center

Enrollment

15,000 participants

Start Date

Mar 20, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.


Eligibility

Min Age: 19 Years

Inclusion Criteria1

  • patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.

Exclusion Criteria1

  • patients who did not consent to the research

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPercutaneous coronary intervention

Percutaneous Coronary Intervention Procedure


Locations(1)

Samsung Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05624905


Related Trials